<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39459567</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>05</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>Accounting for Red Cell Distribution Width Improves Risk Stratification by Commonly Used Mortality/Deterioration Risk Scores in Adult Patients Hospitalized Due to COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1267</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life14101267</ELocationID><Abstract><AbstractText>Higher red blood cell distribution width (RDW) levels have gained attention in the prognostication of many chronic metabolic and malignant diseases, as well as coronavirus disease 2019 (COVID-19). We aimed to evaluate whether accounting for RDW might contribute to risk stratification when added to commonly used risk scoring systems in adult COVID-19 patients. We retrospectively analyzed a cohort of 3212 non-critical COVID-19 patients hospitalized in a tertiary-level institution from March 2020 to June 2021. Admission RDW values were considered normal if they were ≤14.5% in males or ≤16.1% in females. The Modified Early Warning Score (MEWS), International Severe Acute Respiratory and Emerging Infections Consortium Coronavirus Clinical Characterisation Consortium score (ISARIC 4C), and Veterans Health Administration COVID-19 (VACO) index were evaluated as prognostic scores. RDW exceeded the upper limit in 628 (19.6%) of the patients. When RDW was accounted for, risks of the predicted outcomes were considerably different within the same MEWS, 4C score, and VACO index levels. The same patterns applied equally to patients who started, and those who did not start, remdesivir before deterioration. RDW may be a useful tool for stratifying risk when considered on top of commonly used prognostic scores in non-critical COVID-19 patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jordan</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology Department, University Hospital Dubrava, 10000 Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trkulja</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-0968-1194</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jurin</LastName><ForeName>Ivana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Cardiology Department, University Hospital Dubrava, 10000 Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marević</LastName><ForeName>Sanja</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Department for Laboratory Diagnostics, University Hospital Dubrava, 10000 Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Đerek</LastName><ForeName>Lovorka</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Clinical Department for Laboratory Diagnostics, University Hospital Dubrava, 10000 Zagreb, Croatia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Catholic University of Croatia, 10000 Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lukšić</LastName><ForeName>Ivica</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-9138-2037</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maxillofacial Surgery Department, University Hospital Dubrava, 10000 Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manola</LastName><ForeName>Šime</ForeName><Initials>Š</Initials><AffiliationInfo><Affiliation>Cardiology Department, University Hospital Dubrava, 10000 Zagreb, Croatia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Dental Medicine, University of Zagreb, 10000 Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucijanić</LastName><ForeName>Marko</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1372-2040</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hematology Department, University Hospital Dubrava, 10000 Zagreb, Croatia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">anisocytosis</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">mortality</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39459567</ArticleId><ArticleId IdType="pmc">PMC11509295</ArticleId><ArticleId IdType="doi">10.3390/life14101267</ArticleId><ArticleId IdType="pii">life14101267</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dong E., Du H., Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 2020;20:533–534. doi: 10.1016/S1473-3099(20)30120-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 2020;8:420–422. doi: 10.1016/S2213-2600(20)30076-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J., Tong Z., Guan X., Du B., Qiu H., Slutsky A.S. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med. 2020;46:837–840. doi: 10.1007/s00134-020-05979-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05979-7</ArticleId><ArticleId IdType="pmc">PMC7080165</ArticleId><ArticleId IdType="pubmed">32123994</ArticleId></ArticleIdList></Reference><Reference><Citation>Telenti A., Arvin A., Corey L., Corti D., Diamond M.S., García-Sastre A., Garry R.F., Holmes E.C., Pang P.S., Virgin H.W. After the pandemic: Perspectives on the future trajectory of COVID-19. Nature. 2021;596:495–504. doi: 10.1038/s41586-021-03792-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03792-w</ArticleId><ArticleId IdType="pubmed">34237771</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G., Plebani M. Red blood cell distribution width (RDW) and human pathology. One size fits all. Clin. Chem. Lab. Med. 2014;52:1247–1249. doi: 10.1515/cclm-2014-0585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2014-0585</ArticleId><ArticleId IdType="pubmed">24945432</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahan L.L., IV, Ramos J.D.A., Cunanan E.L., Tiongson M.D.A., Punzalan F.E.R. Red Cell Distribution Width and Mortality in Patients with Acute Coronary Syndrome: A Meta-Analysis on Prognosis. Cardiol. Res. 2018;9:144–152. doi: 10.14740/cr732w.</Citation><ArticleIdList><ArticleId IdType="doi">10.14740/cr732w</ArticleId><ArticleId IdType="pmc">PMC5997444</ArticleId><ArticleId IdType="pubmed">29904449</ArticleId></ArticleIdList></Reference><Reference><Citation>Milas G.P., Karageorgiou V., Cholongitas E. Red cell distribution width to platelet ratio for liver fibrosis: A systematic review and meta-analysis of diagnostic accuracy. Expert Rev. Gastroenterol. Hepatol. 2019;13:877–891. doi: 10.1080/17474124.2019.1653757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17474124.2019.1653757</ArticleId><ArticleId IdType="pubmed">31389726</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal H., Awad H., Hu Z.D. Prognostic value of admission red blood cell distribution width in acute pancreatitis: A systematic review. Ann. Transl. Med. 2017;5:342. doi: 10.21037/atm.2017.06.61.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2017.06.61</ArticleId><ArticleId IdType="pmc">PMC5599272</ArticleId><ArticleId IdType="pubmed">28936436</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S.Y., Hua C., Dornbors D., III, Kang R.J., Zhao X.X., Du X., He W., Ding Y.C., Meng R. Baseline Red Blood Cell Distribution Width as a Predictor of Stroke Occurrence and Outcome: A Comprehensive Meta-Analysis of 31 Studies. Front. Neurol. 2019;10:1237. doi: 10.3389/fneur.2019.01237.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.01237</ArticleId><ArticleId IdType="pmc">PMC6901990</ArticleId><ArticleId IdType="pubmed">31849813</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente L., Martín M.M., Abreu-González P., Pérez-Cejas A., González-Rivero A.F., Ramos-Gómez L., Argueso M., Solé-Violán J., Cáceres J.J., Jiménez A., et al. Early Mortality of Brain Infarction Patients and Red Blood Cell Distribution Width. Brain Sci. 2020;10:196. doi: 10.3390/brainsci10040196.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10040196</ArticleId><ArticleId IdType="pmc">PMC7226572</ArticleId><ArticleId IdType="pubmed">32224967</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N., Zhou H., Tang Q. Red Blood Cell Distribution Width: A Novel Predictive Indicator for Cardiovascular and Cerebrovascular Diseases. Dis. Markers. 2017;2017:7089493. doi: 10.1155/2017/7089493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7089493</ArticleId><ArticleId IdType="pmc">PMC5606102</ArticleId><ArticleId IdType="pubmed">29038615</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.J., Montazerin S.M., Jamil A., Jamil U., Marszalek J., Chuang M.L., Chi G. Association between red blood cell distribution width and mortality and severity among patients with COVID-19: A systematic review and meta-analysis. J. Med. Virol. 2021;93:2513–2522. doi: 10.1002/jmv.26797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26797</ArticleId><ArticleId IdType="pmc">PMC8014709</ArticleId><ArticleId IdType="pubmed">33448439</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S., Kannan S., Khanna P., Singh A.K. Role of red blood cell distribution width, as a prognostic indicator in COVID-19: A systematic review and meta-analysis. Rev. Med. Virol. 2022;32:e2264. doi: 10.1002/rmv.2264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2264</ArticleId><ArticleId IdType="pmc">PMC8209859</ArticleId><ArticleId IdType="pubmed">34091982</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnett W.R., Radhakrishnan M., Macko J., Hinch B.T., Altorok N., Assaly R. Initial MEWS score to predict ICU admission or transfer of hospitalized patients with COVID-19: A retrospective study. J. Infect. 2021;82:282–327. doi: 10.1016/j.jinf.2020.08.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.047</ArticleId><ArticleId IdType="pmc">PMC7462753</ArticleId><ArticleId IdType="pubmed">32888979</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight S.R., Ho A., Pius R., Buchan I., Carson G., Drake T.M., Dunning J., Fairfield C.J., Gamble C., Green C.A., et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Development and validation of the 4C Mortality Score. BMJ. 2020;371:m4334. doi: 10.1136/bmj.m3339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3339</ArticleId><ArticleId IdType="pmc">PMC7116472</ArticleId><ArticleId IdType="pubmed">32907855</ArticleId></ArticleIdList></Reference><Reference><Citation>King J.T., Jr., Yoon J.S., Rentsch C.T., Tate J.P., Park L.S., Kidwai-Khan F., Skanderson M., Hauser R.G., Jacobson D.A., Erdos J., et al. Development and validation of a 30-day mortality index based on pre-existing medical administrative data from 13,323 COVID-19 patients: The Veterans Health Administration COVID-19 (VACO) Index. PLoS ONE. 2020;15:e0241825. doi: 10.1371/journal.pone.0241825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0241825</ArticleId><ArticleId IdType="pmc">PMC7657526</ArticleId><ArticleId IdType="pubmed">33175863</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministarstvo Zdravstva Republike Hrvatske  Smjernice za Liječenje Oboljelih od COVID-19, Verzija 1 od 8. Rujna 2020.  [(accessed on 2 May 2024)];2020  Available online:  https://zdravlje.gov.hr/UserDocsImages//2020%20CORONAVIRUS//Smjernice%20za%20liječenje%20oboljelih%20od%20COVID-19,%20verzija%201%20od%2008.09.2020..pdf.</Citation></Reference><Reference><Citation>World Health Organization  Clinical Management of COVID-19: Interim Guidance, Geneva: World Health Organization (2020)  [(accessed on 2 May 2024)].  Available online:  https://apps.who.int/iris/handle/10665/332196.</Citation></Reference><Reference><Citation>Adeli K., Raizman J.E., Chen Y., Higgins V., Nieuwesteeg M., Abdelhaleem M., Wong S.L., Blais D. Complex biological profile of hematologic markers across pediatric, adult, and geriatric ages: Establishment of robust pediatric and adult reference intervals on the basis of the Canadian Health Measures Survey. Clin. Chem. 2015;61:1075–1086. doi: 10.1373/clinchem.2015.240531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2015.240531</ArticleId><ArticleId IdType="pubmed">26044509</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornick A., Tashtish N., Osnard M., Shah B., Bradigan A., Albar Z., Tomalka J., Dalton J., Sharma A., Sekaly R.P., et al. Anisocytosis is Associated with Short-Term Mortality in COVID-19 and May Reflect Proinflammatory Signature in Uninfected Ambulatory Adults. Pathog. Immun. 2020;5:312–326. doi: 10.20411/pai.v5i1.391.</Citation><ArticleIdList><ArticleId IdType="doi">10.20411/pai.v5i1.391</ArticleId><ArticleId IdType="pmc">PMC7556412</ArticleId><ArticleId IdType="pubmed">33089037</ArticleId></ArticleIdList></Reference><Reference><Citation>Guaní-Guerra E., Torres-Murillo B., Muñoz-Corona C., Rodríguez-Jiménez J.C., Macías A.E., Scavo-Montes D.A., Alvarez J.A. Diagnostic Accuracy of the RDW for Predicting Death in COVID-19. Medicina. 2022;58:613. doi: 10.3390/medicina58050613.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58050613</ArticleId><ArticleId IdType="pmc">PMC9144906</ArticleId><ArticleId IdType="pubmed">35630030</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucijanic M., Soric E., Sedicnic Lacko M., Sabljic A., Krecak I., Bistrovic P., Jordan A., Manola S., Jaksic O., Lucijanic T., et al. Gradual increase in red cell distribution width is similarly prognostic for in-hospital mortality in both anemic and non-anemic COVID-19 patients. J. Med. Virol. 2022;94:3509–3511. doi: 10.1002/jmv.27785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27785</ArticleId><ArticleId IdType="pmc">PMC9088494</ArticleId><ArticleId IdType="pubmed">35419812</ArticleId></ArticleIdList></Reference><Reference><Citation>Gama S. RDW shows prognostic potential in hospitalized patients with COVID-19. J. Med. Virol. 2022;94:3498–3500. doi: 10.1002/jmv.27764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27764</ArticleId><ArticleId IdType="pmc">PMC9088635</ArticleId><ArticleId IdType="pubmed">35388503</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry B.M., Benoit J.L., Benoit S., Pulvino C., Berger B.A., Olivera M.H.S., Crutchfield C.A., Lippi G. Red Blood Cell Distribution Width (RDW) Predicts COVID-19 Severity: A Prospective, Observational Study from the Cincinnati SARS-CoV-2 Emergency Department Cohort. Diagnostics. 2020;10:618. doi: 10.3390/diagnostics10090618.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics10090618</ArticleId><ArticleId IdType="pmc">PMC7554711</ArticleId><ArticleId IdType="pubmed">32825629</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran P., Gajendran M., Perisetti A., Elkholy K.O., Chakraborti A., Lippi G., Goyal H. Red Blood Cell Distribution Width in Hospitalized COVID-19 Patients. Front. Med. 2021;8:582403. doi: 10.3389/fmed.2021.582403.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.582403</ArticleId><ArticleId IdType="pmc">PMC8778579</ArticleId><ArticleId IdType="pubmed">35071250</ArticleId></ArticleIdList></Reference><Reference><Citation>Said A.S., Spinella P.C., Hartman M.E., Steffen K.M., Jackups R., Holubkov R., Wallendorf M., Doctor A. RBC Distribution Width: Biomarker for Red Cell Dysfunction and Critical Illness Outcome? Pediatr. Crit. Care Med. 2017;18:134–142. doi: 10.1097/PCC.0000000000001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000001017</ArticleId><ArticleId IdType="pmc">PMC5291765</ArticleId><ArticleId IdType="pubmed">27832023</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvagno G.L., Sanchis-Gomar F., Picanza A., Lippi G. Red blood cell distribution width: A simple parameter with multiple clinical applications. Crit. Rev. Clin. Lab. Sci. 2015;52:86–105. doi: 10.3109/10408363.2014.992064.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10408363.2014.992064</ArticleId><ArticleId IdType="pubmed">25535770</ArticleId></ArticleIdList></Reference><Reference><Citation>Tziakas D., Chalikias G., Grapsa A., Gioka T., Tentes I., Konstantinides S. Red blood cell distribution width: A strong prognostic marker in cardiovascular disease: Is associated with cholesterol content of erythrocyte membrane. Clin. Hemorheol. Microcirc. 2012;51:243–254. doi: 10.3233/CH-2012-1530.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-2012-1530</ArticleId><ArticleId IdType="pubmed">22277951</ArticleId></ArticleIdList></Reference><Reference><Citation>Qurtom H.A., al-Saleh Q.A., Lubani M.M., Hassanein A., Kaddoorah N., Qurtom M.A., al-Sheikh T. The value of red cell distribution width in the diagnosis of anaemia in children. Eur. J. Pediatr. 1989;148:745–748. doi: 10.1007/BF00443100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00443100</ArticleId><ArticleId IdType="pubmed">2792125</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultana G.S., Haque S.A., Sultana T., Rahman Q., Ahmed A.N. Role of red cell distribution width (RDW) in the detection of iron deficiency anaemia in pregnancy within the first 20 weeks of gestation. Bangladesh Med. Res. Counc. Bull. 2011;37:102–105. doi: 10.3329/bmrcb.v37i3.9122.</Citation><ArticleIdList><ArticleId IdType="doi">10.3329/bmrcb.v37i3.9122</ArticleId><ArticleId IdType="pubmed">22352230</ArticleId></ArticleIdList></Reference><Reference><Citation>Emans M.E., Gaillard C.A., Pfister R., Tanck M.W., Boekholdt S.M., Wareham N.J., Khaw K.T. Red cell distribution width is associated with physical inactivity and heart failure, independent of established risk factors, inflammation or iron metabolism; the EPIC-Norfolk study. Int. J. Cardiol. 2013;168:3550–3555. doi: 10.1016/j.ijcard.2013.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2013.05.002</ArticleId><ArticleId IdType="pubmed">23711445</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G., Sanchis-Gomar F., Danese E., Montagnana M. Association of red blood cell distribution width with plasma lipids in a general population of unselected outpatients. Kardiol. Pol. 2013;71:931–936. doi: 10.5603/KP.2013.0228.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/KP.2013.0228</ArticleId><ArticleId IdType="pubmed">24065422</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucijanic M., Krecak I., Soric E., Sabljic A., Galusic D., Holik H., Perisa V., Peric M.M., Zekanovic I., Budimir J., et al. Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis. Life. 2024;14:523. doi: 10.3390/life14040523.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life14040523</ArticleId><ArticleId IdType="pmc">PMC11051164</ArticleId><ArticleId IdType="pubmed">38672793</ArticleId></ArticleIdList></Reference><Reference><Citation>García-Escobar A., Vera-Vera S., Tébar-Márquez D., Rivero-Santana B., Jurado-Román A., Jiménez-Valero S., Galeote G., Cabrera J., Moreno R. Neutrophil-to-lymphocyte ratio an inflammatory biomarker, and prognostic marker in heart failure, cardiovascular disease and chronic inflammatory diseases: New insights for a potential predictor of anti-cytokine therapy responsiveness. Microvasc. Res. 2023;150:104598. doi: 10.1016/j.mvr.2023.104598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2023.104598</ArticleId><ArticleId IdType="pubmed">37633337</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstovsek S., Krečak I., Heidel F.H., De Stefano V., Bryan K., Zuurman M.W., Zaiac M., Morelli M., Smyth A., Redondo S., et al. Identifying Patients with Polycythemia Vera at Risk of Thrombosis after Hydroxyurea Initiation: The Polycythemia Vera—Advanced Integrated Models (PV-AIM) Project. Biomedicines. 2023;11:1925. doi: 10.3390/biomedicines11071925.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11071925</ArticleId><ArticleId IdType="pmc">PMC10377437</ArticleId><ArticleId IdType="pubmed">37509564</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng S., Huang J., Liu X., Deng J., Sun C., Tang J., Chen H., Cao W., Wang W., Duan X., et al. Interpretable machine learning for 28-day all-cause in-hospital mortality prediction in critically ill patients with heart failure combined with hypertension: A retrospective cohort study based on medical information mart for intensive care database-IV and eICU databases. Front. Cardiovasc. Med. 2022;9:994359. doi: 10.3389/fcvm.2022.994359.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.994359</ArticleId><ArticleId IdType="pmc">PMC9597462</ArticleId><ArticleId IdType="pubmed">36312291</ArticleId></ArticleIdList></Reference><Reference><Citation>Prozan L., Shusterman E., Ablin J., Mitelpunkt A., Weiss-Meilik A., Adler A., Choshen G., Kehat O. Prognostic value of neutrophil-to-lymphocyte ratio in COVID-19 compared with Influenza and respiratory syncytial virus infection. Sci. Rep. 2021;11:21519. doi: 10.1038/s41598-021-00927-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-00927-x</ArticleId><ArticleId IdType="pmc">PMC8563769</ArticleId><ArticleId IdType="pubmed">34728719</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J., Dean L.S., Jiyarom B., Gangcuangco L.M., Shah P., Awamura T., Ching L.L., Nerurkar V.R., Chow D.C., Igno F., et al. Elevated circulating monocytes and monocyte activation in COVID-19 convalescent individuals. Front. Immunol. 2023;14:1151780. doi: 10.3389/fimmu.2023.1151780.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1151780</ArticleId><ArticleId IdType="pmc">PMC10106598</ArticleId><ArticleId IdType="pubmed">37077911</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucijanic M., Krecak I., Soric E., Sedinic M., Sabljic A., Derek L., Jaksic O., Kusec R. Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism. Blood Cancer J. 2021;11:189. doi: 10.1038/s41408-021-00585-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41408-021-00585-2</ArticleId><ArticleId IdType="pmc">PMC8629336</ArticleId><ArticleId IdType="pubmed">34845183</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucijanic M., Krecak I., Soric E., Sabljic A., Vasilj T., Cicic D., Vuk A.V., Kremer Z., Dilber I., Glasnovic A., et al. Secondary polycythemia in acutely ill COVID-19 patients is associated with higher mortality but not markedly higher thrombotic risk. Scand. J. Clin. Lab. Investig. 2024;84:84–90. doi: 10.1080/00365513.2024.2321589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365513.2024.2321589</ArticleId><ArticleId IdType="pubmed">38414267</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>